US2014343248A1PendingUtilityA1

Method for enhancing immune response with peptide

Assignee: CHEMO SERO THERAPEUT RES INSTPriority: Apr 20, 2007Filed: Jun 24, 2014Published: Nov 20, 2014
Est. expiryApr 20, 2027(~0.7 yrs left)· nominal 20-yr term from priority
A61P 37/04A61K 39/0007A61P 25/00C07K 14/4711A61K 31/711A61P 25/28
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An object of the present invention is to provide a safe and effective method for enhancing an immune response and a medicament for preventing or treating Alzheimer disease comprising amyloid β peptide that induces an enhanced immune response. An amyloid β peptide or a portion thereof with addition or insertion of cysteine and a method for enhancing an immune response using the peptide or a method for enhancing an immune response using the peptide together with an adjuvant. A medicament for preventing or treating Alzheimer disease comprising an amyloid β peptide or a portion thereof that induces an enhanced immune response. A DNA vaccine, that may have the same effect, comprising the gene encoding an amyloid β peptide or a portion thereof that induces an enhanced immune response with addition or insertion of cysteine.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . An immunogenic peptide that induces an enhanced immune response consisting of amino acids 1-28 of an amyloid β peptide with addition of a cysteine only at the C-terminus.

Join the waitlist — get patent alerts

Track US2014343248A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.